Novel Biodegradable LNPs for Organ/Cell Selective Delivery of mRNA
An effective organ and cell selective delivery system is needed to achieve therapeutic results. Our mission is to solve the delivery challenge associate with drug discovery in particular with nucleic acid-based cargos, with excellent safety, efficiency and organ and cell selectivity.
The technology is licensed from Tufts University. We have identified LNPs that can deliver cargos in organ and cell specific manner. Our mission is to provide cutting-edge technology and services in the field of immunotherapy, gene therapy and gene editing.